ConductScience.org, home

Paper42007189

Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Outcomes.

Parkash R and 5 others. CJC Open, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Outcomes. Papers, record 42007189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007189

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Outcomes.
PubMed
Journal
CJC Open
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Parkash RRatika
2Hayami DDoug
3Caddell AAndrew
4Pirzada AAshar
5Greeley SSuzanne
6Anderson KKim

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119746249Heart failure clinics are associated with clinical benefit in both tertiary and community care settings: data from the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) registry.Can J Cardiol2009https://conductscience.org/library/papers/19746249PubMed
229997002Shortening of paced QRS duration after electrocardiographic optimization of left ventricular pacing vector in patients treated with Cardiac Resynchronization Therapy.J Electrocardiol2018https://conductscience.org/library/papers/29997002PubMed
327206819
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Eur Heart J2016https://conductscience.org/library/papers/27206819PubMed
426940927Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.J Am Coll Cardiol2016https://conductscience.org/library/papers/26940927PubMed
521550578Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy.Am J Cardiol2011https://conductscience.org/library/papers/21550578PubMed
639921334SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices.ESC Heart Fail2025https://conductscience.org/library/papers/39921334PubMed
728461007
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
J Am Coll Cardiol2017https://conductscience.org/library/papers/28461007PubMed
838560378Outcomes with guideline-directed medical therapy and cardiac implantable electronic device therapies for patients with heart failure with reduced ejection fraction.Heart Rhythm O22024https://conductscience.org/library/papers/38560378PubMed
929402420
Effect of Optimization of Medical Treatment on Long-Term Survival of Patients With Heart Failure After Implantable Cardioverter Defibrillator and Cardiac Resynchronization Device Implantation (from the French National EGB Database).
Am J Cardiol2018https://conductscience.org/library/papers/29402420PubMed
1024237881Fusion-optimized intervals (FOI): a new method to achieve the narrowest QRS for optimization of the AV and VV intervals in patients undergoing cardiac resynchronization therapy.J Cardiovasc Electrophysiol2014https://conductscience.org/library/papers/24237881PubMed
1120197509Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures.Circ Cardiovasc Qual Outcomes2010https://conductscience.org/library/papers/20197509PubMed
1233827756CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.Can J Cardiol2021https://conductscience.org/library/papers/33827756PubMed
1339393749Delta QRS and outcomes post CRT in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial.Heart Rhythm2025https://conductscience.org/library/papers/39393749PubMed
1435981790Guideline-Directed Medical Therapy and the Risk of Death in Primary Prevention Defibrillator Recipients.JACC Clin Electrophysiol2022https://conductscience.org/library/papers/35981790PubMed
15291111062017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure.Can J Cardiol2017https://conductscience.org/library/papers/29111106PubMed
16372083012023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic.Europace2023https://conductscience.org/library/papers/37208301PubMed
1739551747Impact of implantable cardioverter defibrillators on mortality in heart failure receiving quadruple guideline-directed medical therapy: a propensity score-matched study.BMC Med2024https://conductscience.org/library/papers/39551747PubMed
1831535829Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.N Engl J Med2019https://conductscience.org/library/papers/31535829PubMed
1923351926Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization therapy: evidence and patient selection.Can J Cardiol2013https://conductscience.org/library/papers/23351926PubMed
2028034580Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines.Can J Cardiol2017https://conductscience.org/library/papers/28034580PubMed

See all 21 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42007189

GET https://conductscience.org/api/papers/v1/42007189/references?page=2